Literature DB >> 6182082

Alpha 2-macroglobulin and proliferative retinopathy in type 1 diabetes.

R S Gray, K James, J Merriman, I R Starkey, R A Elton, B F Clarke, L J Duncan.   

Abstract

Serum alpha 2-macroglobulin (alpha 2m) and total glycosylated haemoglobin (HbA1) concentrations were measured in 110 insulin dependent Type 1 diabetics with minimal or no fundoscopic retinopathy, referred to as non-retinopaths, and in 52 proliferative retinopaths. Proteinuria was recorded in 8 (7%) non-retinopaths and 29 (56%) retinopaths and was accompanied by elevated alpha 2m concentrations in both groups of diabetics but only significantly so in the non-retinopaths. Diabetics without proteinuria showed a significant correlation between alpha 2m concentration and duration of diabetes, HbA1 and age (being higher at extremes of age). Alpha 2m concentrations were significantly higher in retinopaths than in non-retinopaths without proteinuria when allowance was made for the influence of age and duration of diabetes on alpha 2m. This difference may be attributed to the higher HbA, levels found in retinopaths than in non-retinopaths and was no longer evident when account was taken of the prevailing HbA1 concentration in individual patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6182082     DOI: 10.1055/s-2007-1019026

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  6 in total

1.  Reference distributions for alpha2-macroglobulin: a practical, simple and clinically relevant approach in a large cohort.

Authors:  Robert F Ritchie; Glenn E Palomaki; Louis M Neveux; Olga Navolotskaia; Thomas B Ledue; Wendy Y Craig
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

2.  Platelet and coagulation factors in proliferative diabetic retinopathy.

Authors:  D Q Borsey; C V Prowse; R S Gray; J Dawes; K James; R A Elton; B F Clarke
Journal:  J Clin Pathol       Date:  1984-06       Impact factor: 3.411

3.  Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease.

Authors:  Vlad Ratziu; Julien Massard; Frederic Charlotte; Djamila Messous; Françoise Imbert-Bismut; Luninita Bonyhay; Mohamed Tahiri; Mona Munteanu; Dominique Thabut; Jean François Cadranel; Brigitte Le Bail; Victor de Ledinghen; Thierry Poynard
Journal:  BMC Gastroenterol       Date:  2006-02-14       Impact factor: 3.067

4.  Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease.

Authors:  Thierry Poynard; Vlad Ratziu; Frederic Charlotte; Djamila Messous; Mona Munteanu; Françoise Imbert-Bismut; Julien Massard; Luninita Bonyhay; Mohamed Tahiri; Dominique Thabut; Jean François Cadranel; Brigitte Le Bail; Victor de Ledinghen
Journal:  BMC Gastroenterol       Date:  2006-11-10       Impact factor: 3.067

5.  α-2-macroglobulin in saliva is associated with glycemic control in patients with type 2 diabetes mellitus.

Authors:  Juan Pablo Aitken; Carolina Ortiz; Irene Morales-Bozo; Gonzalo Rojas-Alcayaga; Mauricio Baeza; Caroll Beltran; Alejandro Escobar
Journal:  Dis Markers       Date:  2015-03-03       Impact factor: 3.434

6.  Common genetic variants and pathways in diabetes and associated complications and vulnerability of populations with different ethnic origins.

Authors:  Sabrina Samad Shoily; Tamim Ahsan; Kaniz Fatema; Abu Ashfaqur Sajib
Journal:  Sci Rep       Date:  2021-04-05       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.